Harold Bernstein
President at Maze Therapeutics, Inc. (MAZE)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $9.5M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 2SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 16,141 | $26.93 | $435K | +0.7% |
| Sep 8SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 9,705 | $26.22 | $254K | +3.4% |
| Sep 4SEC | MAZEMaze Therapeutics, Inc. | Sell | 4,48115,519 held (−22%) | $26.38 | $118K | +2.8% |
| Sep 4SEC | MAZEMaze Therapeutics, Inc. | Sell | 62514,894 held (−4%) | $27.12 | $17K | -0.0% |
| Sep 4SEC | MAZEMaze Therapeutics, Inc. | Sell | 5,1309,764 held (−34%) | $26.01 | $133K | +4.2% |
| Sep 4SEC | MAZEMaze Therapeutics, Inc. | Sell | 599,705 held (−1%) | $25.78 | $2K | +5.2% |
| Sep 3SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 16,141 | $26.36 | $425K | +2.8% |
| Aug 14SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 16,142 | $27.61 | $446K | -1.8% |
| Jul 2SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 13,4091,200 held (−92%) | $29.87 | $401K | -9.2% |
| Jul 2SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 1,200 | $30.34 | $36K | -10.6% |
| Jun 3SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 13,2531,600 held (−89%) | $25.57 | $339K | +6.0% |
| Jun 3SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 1,600 | $26.36 | $42K | +2.8% |
| May 18SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 15,000 | $26.22 | $393K | +3.4% |
| Apr 2SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 11,3523,648 held (−76%) | $29.24 | $332K | -7.3% |
| Apr 2SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 3,348300 held (−92%) | $30.06 | $101K | -9.8% |
| Apr 2SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 300 | $31.07 | $9K | -12.7% |
| Mar 20SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 6,1618,839 held (−41%) | $48.20 | $297K | -43.8% |
| Mar 20SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 3,7955,044 held (−43%) | $49.32 | $187K | -45.0% |
| Mar 20SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 5,044 | $50.02 | $252K | -45.8% |
| Mar 12SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 29,652348 held (−99%) | $50.45 | $1.5M | -46.3% |
| Mar 12SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 348 | $51.02 | $18K | -46.9% |
| Feb 4SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 60014,400 held (−4%) | $44.21 | $27K | -38.7% |
| Feb 4SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 8,3646,036 held (−58%) | $45.89 | $384K | -40.9% |
| Feb 4SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 5,936100 held (−98%) | $46.37 | $275K | -41.5% |
| Feb 4SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 100 | $47.23 | $5K | -42.6% |
| Jan 9SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 25,156 | $40.20 | $1.0M | -32.6% |
| Jan 6SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 4,432 | $40.43 | $179K | -32.9% |
| Jan 6SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 412 | $40.00 | $16K | -32.2% |
| Dec 31SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 27,80017,200 held (−62%) | $40.34 | $1.1M | -32.8% |
| Dec 31SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 17,200 | $40.93 | $704K | -33.8% |
- Sell
President Harold Bernstein sold $435K of MAZE at $26.93 — pre-scheduled 10b5-1 plan sale.
- Sell
President Harold Bernstein sold $254K of MAZE at $26.22 — pre-scheduled 10b5-1 plan sale.
- Sell
President Harold Bernstein sold $133K of MAZE at $26.01 — cuts the stake by 34%.
- Sell
President Harold Bernstein sold $425K of MAZE at $26.36 — pre-scheduled 10b5-1 plan sale.
- Sell
President Harold Bernstein sold $446K of MAZE at $27.61 — pre-scheduled 10b5-1 plan sale.
- Sell
President Harold Bernstein sold $401K of MAZE at $29.87 — cuts the stake by 92%; pre-scheduled 10b5-1 plan sale.